CSCI   $2.72  -11.69% Market Closed

COSCIENS Biopharma Inc.
Total Cash 27.80M
totalCashPerShare 8.923
EBITDA -17.99M
Total Debt 1.69M
quickRatio 2.946
currentRatio 3.355
Total Revenue 4.92M
debtToEquity 6.432
Revenue/Share 3.759
ROA -0.2334
ROE -0.65924
grossProfits
freeCashflow -7.19M
operatingCashflow -19.27M
earningsGrowth
revenueGrowth 0.041
grossMargins 0.81668
ebitdaMargins 0.0
operatingMargins -1.6067599
profitMargins 0.0
enterpriseValue -15.02M
forwardPE
floatShares 2.89M
sharesOutstanding 3.12M
sharesShort 9.36K
sharesShortPriorMonth 8.96K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.07%
Short Ratio help_outline 1.32%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 8.567
Price To Book help_outline 0.42
earningsQuarterlyGrowth
netIncomeToCommon -18.23M
trailingEps -2.69%
forwardEps
enterpriseToEbitda 0.83
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2024
institutionsCount 14
lastUpdated Nov. 2, 2024, 7:55 a.m.